Skip to content

    Fulgent Genetics (FLGT) stock price & financials

    View FLGT earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance9.4% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $71.74M
    $76.21M
    $73.46M
    $81.80M
    $84.07M
    +17.2%
    $83.34M
    +9.3%
    $71.14M
    -3.2%
    $85.39M
    +4.4%
    Strengthening
    Operating Profit
    -$17.08M
    -$16.14M
    -$19.80M
    -$19.71M
    -$15.35M
    +10.1%
    -$36.24M
    -124.6%
    -$34.62M
    -74.9%
    -$36.07M
    -83.0%
    Weakening
    Net Profit
    -$14.65M
    -$5.89M
    -$11.53M
    -$18.96M
    -$6.61M
    +54.9%
    -$23.42M
    -297.7%
    -$24.83M
    -115.3%
    -$29.53M
    -55.8%
    Weakening
    EPS
    Other Income
    -$1.45M
    $8.10M
    $8.07M
    -$1.81M
    $7.84M
    $6.96M
    -14.0%
    $8.64M
    +7.1%
    $6.38M
    Weakening
    Interest
    $14.0K
    $40.0K
    $14.0K
    $17.0K
    $28.0K
    +100.0%
    $16.0K
    -60.0%
    $17.0K
    +21.4%
    $59.0K
    +247.1%
    Strengthening
    Depreciation
    Profit before Tax
    -$18.53M
    -$8.04M
    -$11.72M
    -$21.52M
    -$7.51M
    +59.5%
    -$29.27M
    -264.2%
    -$25.98M
    -121.6%
    -$29.69M
    -38.0%
    Weakening
    MarginsOPM
    -23.8%
    -21.2%
    -26.9%
    -24.1%
    -18.3%
    +23.3%
    -43.5%
    -105.4%
    -48.7%
    -80.6%
    -42.3%
    -75.3%
    Weakening
    Tax
    20.7%
    23.0%
    -1.5%
    10.5%
    9.1%
    -56.1%
    19.2%
    -16.4%
    2.7%
    -0.1%
    -101.0%
    Weakening
    ReturnsROIC
    -3.1%
    -1.2%
    -2.4%
    -4.0%
    -1.4%
    +54.9%
    -4.9%
    -297.7%
    -5.2%
    -115.3%
    -6.2%
    -55.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$6.74M$11.96M$87.43M$164.89M$79.51M$97.47M$55.14M$50.19M$26.30M
    Short-Term Investments
    Total Current Assets$39.54M$37.08M$523.62M$611.96M$627.87M$507.85M$353.57M$550.49M$454.77M
    Net PP&E$6.45M$8.61M$41.03M$69.43M$96.14M$94.30M$110.94M$117.51M$120.27M
    Goodwill$50.90M$143.03M$22.05M$22.05M$25.08M$53.86M
    Intangibles$35.91M$150.64M$143.05M$134.98M$133.28M$149.26M
    Total Assets$53.90M$88.76M$700.46M$1.28B$1.39B$1.24B$1.22B$1.21B$1.09B
    LiabilitiesTotal Current Liabilities$2.74M$3.72M$130.12M$105.31M$88.11M$73.02M$72.90M$84.97M$71.76M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$2.26M$568.0K$5.34M$8.79M$7.15M$4.12M$3.78M$5.61M
    Total Liabilities$2.75M$5.98M$131.07M$112.84M$116.18M$102.04M$90.81M$106.81M$93.24M
    EquityCommon Stock & APIC$2.0K$2.0K$3.0K$3.0K$3.0K$3.0K$3.0K$3.0K$4.0K
    Retained Earnings-$63.02M-$63.43M$150.88M$657.60M$801.00M$633.17M$590.47M$529.95M$475.60M
    Total Equity$51.15M$82.78M$569.39M$1.16B$1.27B$1.14B$1.13B$1.11B$1.00B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$675.0K$5.52M$140.63M$538.58M$253.52M$27.00M$21.06M-$101.64M-$83.70M
    Cash from Investing$950.0K-$29.05M-$326.44M-$546.55M-$261.31M$38.90M-$58.35M$111.37M$91.98M
    Cash from Financing$15.0K$28.77M$261.25M$85.41M-$77.14M-$47.78M-$4.85M-$14.79M-$70.04M
    SummaryCapital Expenditure-$2.32M-$1.18M-$35.13M-$23.81M-$18.77M-$22.21M-$40.31M-$22.57M-$20.09M
    Free Cash Flow-$3.00M$4.33M$105.50M$514.76M$234.75M$4.80M-$19.25M-$124.21M-$103.79M
    FCF Margin-14.0%13.3%25.0%51.9%37.9%1.7%-6.8%-38.5%-32.0%

    Ratios